- ISIN
- US1266381052
- CUSIP
- 126638105
- Sector
- Healthcare
- Industry
- Medical Devices
- IPO Date
- Jun 30, 2021
Highlights
- Market Cap
- $128.09M
- Enterprise Value
- $114.82M
- EPS (TTM)
- -$2.01
- Total Revenue (TTM)
- $59.07M
- Gross Profit (TTM)
- $50.91M
- EBITDA (TTM)
- -$47.62M
- Year Range
- $4.37 - $11.30
- Target Price
- $10.00
- ROA (TTM)
- -52.80%
- ROE (TTM)
- -180.91%
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
CVRX Performance Chart
CVRx, Inc. (CVRX) is down 31.6% since the beginning of the year. At $5 per share, CVRX is trading 57.0% below its 52-week high of $11.
Loading charts...
Returns By Period
CVRx, Inc. (CVRX) has returned -31.55% so far this year and -17.06% over the past 12 months.
CVRx, Inc.
- 1D
- -1.82%
- 1M
- -20.46%
- YTD
- -31.55%
- 6M
- -37.85%
- 1Y
- -17.06%
- 3Y*
- -30.13%
- 5Y*
- —
- 10Y*
- —
Benchmark (S&P 500 Index)
- 1D
- -0.37%
- 1M
- -0.01%
- YTD
- 9.16%
- 6M
- 8.64%
- 1Y
- 25.22%
- 3Y*
- 19.78%
- 5Y*
- 11.99%
- 10Y*
- 13.88%
CVRX Monthly Returns History
Based on dividend-adjusted daily data since Jun 30, 2021, CVRX's average daily return is +0.04%, while the average monthly return is +0.46%. At this rate, an investment would double in approximately 12.6 years.
Historically, 43% of months were positive and 57% were negative. The best month was Jun 2024 with a return of +72.5%, while the worst month was May 2024 at -55.2%. The longest winning streak lasted 4 consecutive months, and the longest losing streak was 5 months.
On a daily basis, CVRX closed higher 48% of trading days. The best single day was Jun 5, 2024 with a return of +33.9%, while the worst single day was Feb 21, 2023 at -58.8%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -3.52% | 19.12% | 15.93% | -20.61% | -25.70% | -12.90% | -31.55% | ||||||
| 2025 | 26.12% | -18.90% | -5.63% | -40.15% | -9.36% | -11.38% | 35.37% | -1.38% | 2.80% | 26.27% | -3.73% | -27.62% | -43.96% |
| 2024 | -20.10% | -21.86% | -7.23% | -14.83% | -55.19% | 72.52% | -28.69% | 15.32% | -10.65% | 48.92% | 16.77% | -17.30% | -59.70% |
| 2023 | -17.17% | -26.84% | -16.19% | 24.89% | 7.56% | 23.32% | 16.13% | -3.23% | -12.56% | -11.80% | 52.99% | 53.59% | 71.34% |
| 2022 | -32.13% | 5.78% | -31.78% | 4.01% | -0.32% | -3.22% | 46.92% | -17.89% | 28.69% | 8.04% | 32.74% | 37.14% | 50.04% |
| 2021 | 6.67% | -29.50% | -3.44% | -13.22% | 2.24% | -31.52% | 5.61% | -53.41% |
Benchmark Metrics
CVRx, Inc. has an annualized alpha of -8.02%, beta of 1.53, and R2 of 0.08 versus S&P 500 Index. Calculated based on daily prices since June 30, 2021.
- This stock participated in 174.07% of S&P 500 Index downside but only 15.25% of its upside - more exposed to losses than it benefited from rallies.
- R2 of 0.08 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- -8.02%
- Beta
- 1.53
- R²
- 0.08
- Upside Capture
- 15.25%
- Downside Capture
- 174.07%
Return for Risk
Risk / Return Rank
CVRX ranks 33 for risk / return — below 33% of stocks on our site. The returns aren't fully compensating for the risk involved. This isn't necessarily a dealbreaker, but factor it into your decision — especially if you're risk-averse.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for CVRx, Inc. (CVRX) and compare them to S&P 500 Index.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| CVRX | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.25 | ||
| Sortino ratioReturn per unit of downside risk | -2.55 | ||
| Omega ratioGain probability vs. loss probability | 1.03 | 1.37 | -0.34 |
| Calmar ratioReturn relative to maximum drawdown | -0.31 | 2.78 | -3.09 |
| Martin ratioReturn relative to average drawdown | -0.62 | 12.44 | -13.06 |
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the CVRx, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the CVRx, Inc. was 85.64%, occurring on Feb 17, 2026. The portfolio has not yet recovered.
The current CVRx, Inc. drawdown is 85.28%.
Related event | Drawdown | Fall | Recovery | Underwater |
|---|---|---|---|---|
2026 bear market2026 | -85.64%Feb 2026 | 2y 1mo | — | 2y 5moDec 2023 - now |
Bear market2022 | -83.21%Apr 2022 | 9mo 21d | 1y 8mo | 2y 5moJul 2021 - Dec 2023 |
2023 pullback2023 | -0.93%Dec 2023 | 0s | 1d | 1dDec 2023 - Dec 2023 |
Drawdown Indicators
| CVRX | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -85.64% | -56.78% | -28.86% |
Max Drawdown (1Y)Largest decline over 1 year | -56.15% | -9.10% | -47.05% |
Max Drawdown (3Y)Largest decline over 3 years | -85.64% | -18.90% | -66.74% |
Max Drawdown (5Y)Largest decline over 5 years | — | -25.43% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -33.92% | — |
Current DrawdownCurrent decline from peak | -85.28% | -1.80% | -83.48% |
Average DrawdownAverage peak-to-trough decline | -60.58% | -10.71% | -49.87% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 27.36% | 2.03% | +25.33% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of CVRx, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how CVRx, Inc. is priced in the market compared to other companies in the Medical Devices industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for CVRX relative to other companies in the Medical Devices industry. Currently, CVRX has a P/S ratio of 2.2. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for CVRX in comparison with other companies in the Medical Devices industry. Currently, CVRX has a P/B value of 4.4. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with CVRX
Add CVRx, Inc. to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with CVRX